Article
First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.
Hematological oncology - 1 Dec 2017
Meunier Godelieve, Ysebaert Loic, Nguyen-Thi Phi Linh, Lepretre Stéphane, Quinquenel Anne, Dupuis Jehan, Lemal Richard, Aurran Thérèse, Tomowiak Cécile, Cymbalista Florence, Dilhuydy Marie Sarah, Brion Annie, Morel Pierre, Cazin Bruno, Leblond Véronique, Cartron Guillaume, Ré Daniel, Béné Marie Christine, Michallet Anne Sophie, Feugier Pierre
Abstract excerpt
The mean age at diagnosis of chronic lymphocytic leukemia (CLL) is 72 years, with 22.8% of patients being older than 80 years. However, the elderly are underrepresented in clinical studies of CLL. We performed a retrospective study of CLL patients aged 80 years or older at the initiation of first-line therapy in hospitals affiliated with the French intergroup on CLL (French Innovative Leukemia Organization)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.